Plain-English translation of NCT07225894 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether watching theater performances can help reduce stigma and negative attitudes around PrEP (pre-exposure prophylaxis), which is a medication that helps prevent HIV infection. Researchers in Kenya created six short plays that tell stories about young women and HIV prevention, and they want to see if watching these plays helps change how communities think about this medication.
Many young women who could benefit from this medication face shame and judgment from their communities, which can prevent them from using it or talking openly about it. This trial aims to see if storytelling through theater is an effective and practical way to reduce that stigma and support better health decisions.
If you are selected for the intervention group, you will attend all six theater performances within a single week and share your thoughts about the plays afterward. If you are in the control group, you will not watch the plays but may be asked to answer questions about your attitudes toward HIV prevention. Some participants will be invited from the audience after the first performance, while others may join as general audience members.
AI-generated summary from trial data ยท Jun 29, 2026 ยท Not medical advice
Kenya
Collaborators
National Institutes of Health (NIH), Fogarty International Center of the National Institute of Health
Enrollment target
~144 participants
Started
December 2025
Primary completion
March 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.